Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 914335 | ISIN: DK0010268366 | Ticker-Symbol: P1F
Frankfurt
27.06.25 | 08:07
1,270 Euro
-1,17 % -0,015
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
COLUMBUS A/S Chart 1 Jahr
5-Tage-Chart
COLUMBUS A/S 5-Tage-Chart
RealtimeGeldBriefZeit
1,2751,38013:03

Aktuelle News zur COLUMBUS A/S Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.06.Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them2
COLUMBUS A/S Aktie jetzt für 0€ handeln
26.05.Columbus A/S: Columbus has completed strategic review2
08.05.Columbus A/S: Columbus Interim Report Q1 2025124Company announcement no. 5/2025 Solid operational performance in Q1 2025 Columbus delivered a solid start to 2025, driven by improved earnings, confirming the robustness of the strategy and business...
► Artikel lesen
29.04.Passing of Columbus A/S' Annual General Meeting and subsequent constitution of the Board of Directors1
02.04.Columbus A/S: Notice to convene Annual General Meeting2
13.03.Columbus A/S: Annual Report 2024334Company announcement no. 2/20252024 financial performance: Continued growth and solid EBITDA margin Columbus' revenue amounted to DKK 1,659m in 2024, corresponding to an increase of 8%. Organically...
► Artikel lesen
17.01.Columbus A/S: Preliminary unaudited financial results for 2024, financial guidance for 2025 and decision to initiate a strategic review605Company announcement no. 1/2025 Columbus A/S announces preliminary unaudited financial results for 2024, financial guidance for 2025 and decision to initiate a strategic review, which could lead to...
► Artikel lesen
05.11.24Columbus A/S: Interim Report Q3 2024234Company announcement no. 20/2024 Revenue growth continues in Q3 Revenue growth of 8% in Q3 2024, driven by our Cloud ERP Business Line, Dynamics as well as Data & AI and CXE. Strong progress in...
► Artikel lesen
22.08.24Columbus A/S: Interim Report Q2 2024297Company announcement no. 15/2024 Key Business Lines sustaining momentum in Q2 The development in Q2 2024 reflects a strong momentum in the majority of our business with particular strong performance...
► Artikel lesen
9 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1